Protect your dog for longer with an innovative prescription medicine only your vet can offer.
Ask your vet about Bravecto today.
The longest lasting chewable protection ever keeps dogs protected for up to 12 weeks.*
Bravecto is clinically proven safe for dogs1 but is deadly for fleas and ticks.
Bravecto rapidly kills and continuously protects dogs from both fleas and ticks.6
With only 4 doses required for nearly a full year of protection, you gain fewer chances to forget.
Bravecto’s long-lasting protection doesn’t compromise on safety – in fact, it has an excellent safety profile. We’ve put our treatment to the test with comprehensive safety studies that stand up to all scrutiny so that you can be confident you’re providing your dog pet-friendly protection.
Bravecto is proven safe for dogs, and can even be used alongside other medications.1
Only your vet can provide this level of safety.
Ask them about Bravecto today.
Only your vet can provide this level of safety.
Ask them about Bravecto today.
The veterinarian is the expert on pet health and can advise on the best and most appropriate treatments for pets.
Once Bravecto is administered, it is readily absorbed into the animal’s blood stream from the stomach. It’s active ingredient, fluralaner, works safely and systemically inside the dog. The medicine then distributes and persists for up to 12 weeks. During that time, the moment fleas and ticks attach to feed, they ingest fluralaner – paralyzing them – and they are quickly killed.1
No interactions using Bravecto alongside other commonly used drugs were observed.7 However, it is always best to discuss all of your dog’s treatments, whether prescription or over-the-counter supplements, with your veterinarian as they are your dog’s healthcare expert.
No
In a field study where dogs were treated at home, Bravecto Chew was readily accepted by dogs 92.5% of the time.2
Bravecto can be given to your dog any time of the day.
No.
* BRAVECTO is effective against Rhipicephalus sanguineus (brown dog tick) for 8 weeks after dosing. The most common adverse reactions were mild and short-lived vomiting, decreased appetite, diarrhea and drooling. For complete safety information, refer to product label.
1 Bravecto [prescribing information]. Madison, NJ: MSD Animal Health; 2014.
2 Meadows et al. Parasites & Vectors 2014, 7:375
3 Data on file [based on CEESA estimated ectoparasite product sales for 2013 and global estimates of the pet population visiting veterinarians in 2013].
4 Gassel et al. Elsevier 45 (2014): 111-124. ScienceDirect. Web. 11 Sept. 2015.
5 Dryden et al. Parasites & Vectors 2013, 6:126
6 Taenzler et al. Parasites & Vectors 2014, 7:567
7 Walther et al. Parasites & Vectors 2014, 7:481
Copyright © Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved